Speedier drug approvals hit slowdown as FDA faces scrutiny

Norge Nyheter Nyheter

Speedier drug approvals hit slowdown as FDA faces scrutiny
Norge Siste Nytt,Norge Overskrifter
  • 📰 AP
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

The FDA is granting fewer accelerated approvals and pushing more drugmakers to remove unproven uses from their medicines. The tougher stance comes as accelerated approval faces new scrutiny.

Amid the latest controversy, FDA leaders have taken unprecedented steps suggesting a tougher stance on accelerated approval: nudging drugmakers to remove a growing list of unproven uses for drugs and asking Congress for new powers to expedite removals when companies balk.

Launched in 1992, the accelerated approval program is credited with speeding the availability of early breakthroughs for HIV and cancer. About 300 drug approvals have been made that way, nearly half of them in the last five years.But researchers and government watchdogs have chronicled problems with FDA’s oversight, including delays in quickly removing drugs with failed or missing confirmatory studies.

“We need more teeth in terms of getting the confirmatory trials started before accelerated approval,” FDA Commissioner Robert Califf said at a recent cancer conference. “Once approval occurs it’s very difficult to hold back the marketeers.” To be sure, FDA approval trends are impacted by a variety of forces. The agency’s overall tally of novel drugs is down markedly this year at about 30, compared with 50 last year. And even the recent peak in use of the accelerated pathway — 45 approvals in 2020 — reflected several trends.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

AP /  🏆 728. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Speedier drug approvals hit slowdown as FDA faces scrutinySpeedier drug approvals hit slowdown as FDA faces scrutinyThe Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs
Les mer »

Will There Be a Recession in 2023?Will There Be a Recession in 2023?While many predict a recession next year, some say the US could avoid an economic downturn in 2023. See potential bias and similarities in coverage from washingtonpost, azcentral and dcexaminer: Recession Economy
Les mer »

On this day in history, Dec. 6, 1884, Washington Monument completed 39 years after construction beganOn this day in history, Dec. 6, 1884, Washington Monument completed 39 years after construction beganThe Washington Monument in Washington, D.C., dedicated to George Washington, was completed on Dec. 6, 1884, after nearly four decades of construction.
Les mer »

FDA: Frozen raspberries recalled due to possible Hepatitis A contaminationFDA: Frozen raspberries recalled due to possible Hepatitis A contaminationAccording to the recall, FDA testing indicated the presence of Hepatitis A in a select lot of James Farm branded frozen raspberries.
Les mer »

FDA needs messaging campaign to ease gay, bisexual men into blood donation: Medical expertsFDA needs messaging campaign to ease gay, bisexual men into blood donation: Medical expertsThe Food and Drug Administration needs to prioritize a health messaging campaign to ease gay and bisexual men into donating blood, medical experts say, after the organization announced its plan to lift restrictions.
Les mer »



Render Time: 2025-03-06 19:38:43